Pediatric Data Planning Should Start While Adult Drug Development Is In Its Infancy

Innovative trial designs and biostatistics can make pediatric drug development more efficient, but strategies like extrapolating adult data using bridging biomarkers or Bayesian analyses have complex data requirements that demand coordination and forethought.

pediatric patient with doctor (Alamy)
• Source: Alamy

More from Clinical Trials

More from R&D